Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1988 Apr;56(4):947–953. doi: 10.1128/iai.56.4.947-953.1988

Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice.

T Iwahi 1, A Imada 1
PMCID: PMC259396  PMID: 2894364

Abstract

Two type 1 fimbria-producing strains of Escherichia coli, 31-B and K12W1-3, and two type 1 fimbriae-defective mutants derived from 31-B, BH5 and BH9, were compared for their capacity to induce vesical infection in mice undergoing water diuresis and to interact in vitro with murine peritoneal exudate polymorphonuclear leukocytes (PMN). Strains 31-B and BH5 caused rapid bacterial multiplication in the bladder wall after being inoculated intrabladderly; their log-phase cells grown at 37 degrees C, in striking contrast to their stationary-phase or 17 degrees C-grown cells, resisted phagocytic killing by PMN in the presence of normal murine serum. Strains K12W1-3 and BH9 failed to cause vesical infection, and their cells were always susceptible to the opsonophagocytic killing by PMN irrespective of the growth conditions. Nevertheless, the log-phase cells of the three isogenic strains, 31-B, BH5, and BH9, grown at 37 degrees C gave almost the same chemiluminescent response patterns during incubation with PMN in normal serum. The phagocytic resistance in strains 31-B and BH5 was eliminated by briefly treating bacterial cells with EDTA. These results suggest that the two virulent strains may express an antiphagocytic activity during their growth in the bladder and continue to stimulate the oxidative metabolic burst of PMN without being ingested and killed, and that the antiphagocytic activity may be related to a bacterial surface component(s) that is removed by EDTA.

Full text

PDF
947

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agüero M. E., Aron L., DeLuca A. G., Timmis K. N., Cabello F. C. A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis. Infect Immun. 1984 Dec;46(3):740–746. doi: 10.1128/iai.46.3.740-746.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bjornson A. B., Michael J. G. Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria. Infect Immun. 1971 Oct;4(4):462–467. doi: 10.1128/iai.4.4.462-467.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blumenstock E., Jann K. Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili. Infect Immun. 1982 Jan;35(1):264–269. doi: 10.1128/iai.35.1.264-269.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brigham K. L., Meyrick B. Interactions of granulocytes with the lungs. Circ Res. 1984 Jun;54(6):623–635. doi: 10.1161/01.res.54.6.623. [DOI] [PubMed] [Google Scholar]
  5. Brown M. R., Williams P. The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol. 1985;39:527–556. doi: 10.1146/annurev.mi.39.100185.002523. [DOI] [PubMed] [Google Scholar]
  6. Bryant R. E., Sutcliffe M. C., McGee Z. A. Human polymorphonuclear leukocyte function in urine. Yale J Biol Med. 1973 Apr;46(2):113–124. [PMC free article] [PubMed] [Google Scholar]
  7. CHERNEW I., BRAUDE A. I. Depression of phagocytosis by solutes in concentrations found in the kidney and urine. J Clin Invest. 1962 Oct;41:1945–1953. doi: 10.1172/JCI104652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cobbs C. G., Kaye D. Antibacterial mechanisms in the urinary bladder. Yale J Biol Med. 1967 Oct;40(2):93–108. [PMC free article] [PubMed] [Google Scholar]
  9. Densen P., Mandell G. L. Phagocyte strategy vs. microbial tactics. Rev Infect Dis. 1980 Sep-Oct;2(5):817–838. doi: 10.1093/clinids/2.5.817. [DOI] [PubMed] [Google Scholar]
  10. Edén C. S., Hagberg L., Hanson L. A., Korhonen T., Leffler H., Olling S. Adhesion of Escherichia coli in urinary tract infection. Ciba Found Symp. 1981;80:161–187. doi: 10.1002/9780470720639.ch11. [DOI] [PubMed] [Google Scholar]
  11. Fantone J. C., Ward P. A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982 Jun;107(3):395–418. [PMC free article] [PubMed] [Google Scholar]
  12. Gillon G., Small M., Medalia O., Aronson M. Sequential study of bacterial clearance in experimental cystitis. J Med Microbiol. 1984 Dec;18(3):319–326. doi: 10.1099/00222615-18-3-319. [DOI] [PubMed] [Google Scholar]
  13. Hagberg L., Engberg I., Freter R., Lam J., Olling S., Svanborg Edén C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun. 1983 Apr;40(1):273–283. doi: 10.1128/iai.40.1.273-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hagberg L., Hull R., Hull S., Falkow S., Freter R., Svanborg Edén C. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun. 1983 Apr;40(1):265–272. doi: 10.1128/iai.40.1.265-272.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horwitz M. A. Phagocytosis of microorganisms. Rev Infect Dis. 1982 Jan-Feb;4(1):104–123. doi: 10.1093/clinids/4.1.104. [DOI] [PubMed] [Google Scholar]
  16. Horwitz M. A., Silverstein S. C. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980 Jan;65(1):82–94. doi: 10.1172/JCI109663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Iwahi T., Abe Y., Nakao M., Imada A., Tsuchiya K. Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice. Infect Immun. 1983 Mar;39(3):1307–1315. doi: 10.1128/iai.39.3.1307-1315.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iwahi T., Abe Y., Tsuchiya K. Virulence of Escherichia coli in ascending urinary-tract infection in mice. J Med Microbiol. 1982 Aug;15(3):303–316. doi: 10.1099/00222615-15-3-303. [DOI] [PubMed] [Google Scholar]
  19. Leive L., Shovlin V. K., Mergenhagen S. E. Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem. 1968 Dec 25;243(24):6384–6391. [PubMed] [Google Scholar]
  20. Leive L. The barrier function of the gram-negative envelope. Ann N Y Acad Sci. 1974 May 10;235(0):109–129. doi: 10.1111/j.1749-6632.1974.tb43261.x. [DOI] [PubMed] [Google Scholar]
  21. Maeda S., Deguchi T., Kanimoto Y., Kuriyama M., Kawada Y., Nishiura T. Studies on the phagocytic function of urinary leukocytes. J Urol. 1983 Feb;129(2):427–429. doi: 10.1016/s0022-5347(17)52131-x. [DOI] [PubMed] [Google Scholar]
  22. Mangan D. F., Snyder I. S. Mannose-sensitive stimulation of human leukocyte chemiluminescence by Escherichia coli. Infect Immun. 1979 Dec;26(3):1014–1019. doi: 10.1128/iai.26.3.1014-1019.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nakamura K., Mizushima S. In vitro reassembly of the membranous vesicle from Escherichia coli outer membrane components. Role of individual components and magnesium ions in reassembly. Biochim Biophys Acta. 1975 Dec 16;413(3):371–393. doi: 10.1016/0005-2736(75)90122-4. [DOI] [PubMed] [Google Scholar]
  24. Norden C. W., Green G. M., Kass E. H. Antibacterial mechanisms of the urinary bladder. J Clin Invest. 1968 Dec;47(12):2689–2700. doi: 10.1172/JCI105952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ofek I., Mosek A., Sharon N. Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infect Immun. 1981 Dec;34(3):708–711. doi: 10.1128/iai.34.3.708-711.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ohman L., Hed J., Stendahl O. Interaction between human polymorphonuclear leukocytes and two different strains of type 1 fimbriae-bearing Escherichia coli. J Infect Dis. 1982 Dec;146(6):751–757. doi: 10.1093/infdis/146.6.751. [DOI] [PubMed] [Google Scholar]
  27. Orikasa S., Hinman F., Jr Reaction of the vesical wall to bacterial penetration: resistance to attachment, desquamation, and leukocytic activity. Invest Urol. 1977 Nov;15(3):185–193. [PubMed] [Google Scholar]
  28. Peterson P. K., Quie P. G. Bacterial surface components and the pathogenesis of infectious diseases. Annu Rev Med. 1981;32:29–43. doi: 10.1146/annurev.me.32.020181.000333. [DOI] [PubMed] [Google Scholar]
  29. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rosenthal R. S., Fulbright R. S., Eads M. E., Sawyer W. D. Ethylenediaminetetraacetic acid-sensitive antiphagocytic activity of Neisseria gonorrhoeae. Infect Immun. 1977 Mar;15(3):817–827. doi: 10.1128/iai.15.3.817-827.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SINSHEIMER R. L., STARMAN B., NAGLER C., GUTHRIE S. The process of infection with bacteriophage phi-XI74. I. Evidence for a "replicative form". J Mol Biol. 1962 Mar;4:142–160. doi: 10.1016/s0022-2836(62)80047-3. [DOI] [PubMed] [Google Scholar]
  32. Shahin R. D., Engberg I., Hagberg L., Svanborg Edén C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol. 1987 May 15;138(10):3475–3480. [PubMed] [Google Scholar]
  33. Shand G. H., Anwar H., Kadurugamuwa J., Brown M. R., Silverman S. H., Melling J. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun. 1985 Apr;48(1):35–39. doi: 10.1128/iai.48.1.35-39.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stadler J., Aronson M., Medalia O., Griffel B. Spontaneous bacterial clearance in experimental urinary tract infections in mice: cellular aspects of the process. Nephron. 1980;25(6):288–292. doi: 10.1159/000181860. [DOI] [PubMed] [Google Scholar]
  35. Svanborg-Edén C., Hagberg L., Hull R., Hull S., Magnusson K. E., Ohman L. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun. 1987 May;55(5):1224–1232. doi: 10.1128/iai.55.5.1224-1232.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ward P. A., Kunkel S. L. Bacterial virulence and the inflammatory system. Rev Infect Dis. 1983 Sep-Oct;5 (Suppl 4):S793–S796. doi: 10.1093/clinids/5.supplement_4.s793. [DOI] [PubMed] [Google Scholar]
  37. Wilson M. E. Effects of bacterial endotoxins on neutrophil function. Rev Infect Dis. 1985 May-Jun;7(3):404–418. doi: 10.1093/clinids/7.3.404. [DOI] [PubMed] [Google Scholar]
  38. van Alphen L., Verkleij A., Leunissen-Bijvelt J., Lugtenberg B. Architecture of the outer membrane of Escherichia coli. III. Protein-lipopolysaccharide complexes in intramembraneous particles. J Bacteriol. 1978 Jun;134(3):1089–1098. doi: 10.1128/jb.134.3.1089-1098.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES